Expression modes and clinical manifestations of latent membrane protein 1, Ki‐67, cyclin‐B1, and epidermal growth factor receptor in nonendemic nasopharyngeal carcinoma
Authors:
- Zahra Taheri‐KadkhodaZTZahra Taheri‐Kadkhoda
- Bengt MagnussonBMBengt Magnusson
- Marie SvenssonMSMarie Svensson
- Thomas Björk‐ErikssonTBThomas Björk‐Eriksson
- 11 March 2009
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 31 (4) , 482-492
Abstract
Background: We aimed to identify clinical significance of latent membrane protein 1 (LMP1), Ki‐67, cyclin‐B1, and epidermal growth factor receptor (EGFR), in nonendemic nasopharyngeal carcinoma (NPC).Methods: The relation between expression of the markers in 45 NPC specimens and clinicopathological and survival variables was statistically analyzed.Results: LMP1 was present in 33% of the tumors, and its presence was associated with advanced nodal and disease stages. Overexpression was defined as labeling index ≥ median value for Ki‐67, ≥ 15% for cyclin‐B1, and ≥50% for EGFR, and it was displayed in 50%, 55%, and 80% of the specimens, respectively. Strong EGFR staining intensity and not overexpression of the 3 markers was the variable with statistically significant impact on treatment outcomes in terms of worse local and locoregional tumor control rates.Conclusions: Our results suggest that the evaluation of EGFR staining intensity in patients with NPC may identify a subgroup of patients with poor prognosis. © 2009 Wiley Periodicals, Inc. Head Neck, 2009Keywords
This publication has 30 references indexed in Scilit:
- Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patientsInternational Journal of Oral and Maxillofacial Surgery, 2006
- Detection of Cyclin B1 Expression in G1-Phase Cancer Cell Lines and Cancer Tissues by Postsorting Western Blot AnalysisCancer Research, 2004
- Epidermal Growth Factor Receptor in Undifferentiated Carcinoma of the NasopharynxThe Laryngoscope, 2004
- Epstein-barr virus latent membrane protein 1: Structure and functionsJournal of Biomedical Science, 2003
- Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-κB and AP-1Cell Research, 2003
- Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological studyJournal of Cancer Research and Clinical Oncology, 2002
- Induction of c-Met Proto-Oncogene by Epstein-Barr Virus Latent Membrane Protein-1 and the Correlation with Cervical Lymph Node Metastasis of Nasopharyngeal CarcinomaThe American Journal of Pathology, 2001
- Epstein‐Barr Virus‐encoded Latent Membrane Protein 1 Co‐expresses with Epidermal Growth Factor Receptor in Nasopharyngeal CarcinomaJapanese Journal of Cancer Research, 1999
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomasHead & Neck, 1991